PYPei-Wu Yu

Pei-Wu Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pei-Wu Yu has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Retracted

    miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis

    by Yan Shi, Yong-Jia Tan, Dong-Zhu Zeng, Feng Qian, Pei-Wu Yu

    MicroRNAs (miRNAs) play critical roles in tumorigenesis and cancer metastasis. Recently, miR-203 was reported as a tumor suppressor microRNA silenced in different malignancies including hepatocellular carcinoma, prostate cancer, oral cancer, breast cancer, and hematopoietic malignancy, whereas its role in the carcinogenesis of gastric carcinoma (GC) has not been evaluated. Here, we analyzed the levels of miR-203 and Slug in the GC specimen and studied their correlation. We analyzed the binding of miR-203 to the 3′-UTR of Slug messenger RNA (mRNA) and its effects on Slug translation by bioinformatics analysis and by luciferase-reporter assay, respectively. We modified miR-203 levels in GC cells and studied their effects on the cell invasiveness in transwell cell migration assay. We found that in GC, miR-203 levels were significantly decreased and Slug levels were significantly increased. miR-203 and Slug inversely correlated in patients’ specimen. Bioinformatic analysis predicted that miR-203 may target the 3′-UTR of Slug mRNA to inhibit its translation, which was confirmed by luciferase-reporter assay. Overexpression of miR-203 inhibited Slug and cell invasiveness, while depletion of miR-203 increased Slug and cell invasiveness. These data suggest that miR-203 suppression in GC promotes Slug-mediated cancer metastasis.


    • 1 June 2015
      • Vol. 8  (6) , 7002-8

    Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients.

    by Yu-Xing Jiang, Ping-Ang Li, Shi-Wei Yang, Ying-Xue Hao, Pei-Wu Yu

    Previous researchers have identified that the chemokine interleukin-17 (IL-17) was associated with survival time of patients with gastric cancer, but the roles of its receptors (IL-17R) in gastric cancer remain unknown. Our studies were designed to clarify the function of IL-17RA and to explore their potential role in gastric cancer. The expression of IL-17RA was determined in primary gastric cancer tissues (n=101) using Real-time RT-PCR, immunohistochemistry, and western blotting. To investigate the functional significance of IL-17RA expression, IL-17RA expression and clinical parameters, multivariate survival was analyzed in patients with gastric cancer. IL-17RA was overexpression in gastric cancer tissues compared with adjacent normal tissues (P<0.05). The elevated expression level of IL-17RA was observed correlated significantly with tumor progression (P=0.003), Lymphatic invasion (P=0.019), lymphoid nodal status (P=0.001), distant metastasis (P<0.001) of gastric cancer patients, TNM stage (P=0.0013) and was one of the independent prognostic factors for patient's overall survival. These results demonstrated that the expression of IL-17RA plays an important role in gastric cancer progression, migration and prognosis of gastric cancer. The IL-17-IL-17RA signaling mechanism may be a potential novel target.


  • Open Access

    8th Annual Meeting of Chinese College of Surgeons and 19th Annual Meeting of the European Society of Surgery

    by Dequan Xu, Wenjie Dai, Wang Xiaoran, Qi Wang, Hui Liu, Zhou Chaoxi, Guanglin Wang, Wang Guiying, Guiying Wang, Liu Hongbin, et al.


  • Evaluation of Clavien–Dindo classification in patients undergoing total gastrectomy for gastric cancer

    by Junfeng Zhou, Peiwu Yu, Yan Shi, Bo Tang, Yingxue Hao, Yongliang Zhao, Feng Qian

    The Clavien–Dindo classification for postoperative complications has been established as a standardized system and applied in many fields of surgery. The aim of our study was to assess the complications after total gastrectomy using the Clavien–Dindo classification and identify risk factors related to them. Four hundred and fifteen patients who underwent total gastrectomy for gastric cancer between April 2009 and September 2014 were enrolled in this study. Postoperative complications were graded, and possible risk factors related to complications were analyzed. The overall complication rate was 13.3 %, with the severe complications classified as grade III or above accounting for 3.1 %. Age of 65 years old or more, higher TNM staging, and open surgery were identified as independent risk factors for overall complications. Age of 65 years old or more, ASA score of 3 or more, multiorgan resection, and retrieved lymph nodes of 30 or more were identified as independent risk factors for severe complications. The Clavien–Dindo system has a broad applicability and facilitates the assessment on the incidence and severity of complications. Large-scaled, prospective clinical trials using the classification are necessary to evaluate the postoperative complications of total gastrectomy for gastric cancer.


  • Open Access

    Diversity index of mucosal resident T lymphocyte repertoire predicts clinical prognosis in gastric cancer

    by Qingzhu Jia, Junfeng Zhou, Gang Chen, Yan Shi, Haili Yu, Peng Guan, Regina Lin, Ning Jiang, Peiwu Yu, Qi-Jing Li, et al.

    A characteristic immunopathology of human cancers is the induction of tumor antigen-specific T lymphocyte responses within solid tumor tissues. Current strategies for immune monitoring focus on the quantification of the density and differentiation status of tumor-infiltrating T lymphocytes; however, properties of the TCR repertoire ‒ including antigen specificity, clonality, as well as its prognostic significance ‒ remain elusive. In this study, we enrolled 28 gastric cancer patients and collected tumor tissues, adjacent normal mucosal tissues, and peripheral blood samples to study the landscape and compartmentalization of these patients’ TCR β repertoire by deep sequencing analyses. Our results illustrated antigen-driven expansion within the tumor compartment and the contracted size of shared clonotypes in mucosa and peripheral blood. Most importantly, the diversity of mucosal T lymphocytes could independently predict prognosis, which strongly underscores critical roles of resident mucosal T-cells in executing post-surgery immunosurveillance against tumor relapse.


  • Cumulative summation analysis of learning curve for robot‐assisted gastrectomy in gastric cancer

    by Junfeng Zhou, Yan Shi, Feng Qian, Bo Tang, Yingxue Hao, Yongliang Zhao, Peiwu Yu

    Background: The purpose of this study was to determine the learning curve for robot‐assisted gastrectomy using the Cumulative Summation (CUSUM) technique.Methods: Two series of consecutive robotic gastrectomy were retrospective analyzed. Patient demographics, surgical performance, and short‐term outcomes were examined and data of operation time were abstracted for the learning curve analysis.Results: Similar processes occurred in the two surgeons. Each of their learning curves of robotic gastrectomy was best modeled as a third‐order polynomial, with equation CUSUMOT in minutes equal to 0.0495 case number 3 − 4.217 case number2 + 91.206 case number − 100.11(R2 = 0.8731) for surgeon A and 0.0314 case number 3 − 2.4106 case number2 + 33.682 case number + 315.28(R2 = 0.8816) for surgeon B. They both included three unique phases: an initial phase, a well‐developed phase, and a mastery phase after the accumulation of additional experience.Conclusion: The CUSUM method is a useful tool for objective evaluation of practical skills for surgeons during the learning phase of robotic surgery training. The robotic gastrectomy is found to have a short learning curve for experienced laparoscopic surgeons and the popularity of this new technology won't reduce because of its difficulty to learn. J. Surg. Oncol. 2015 111:760–767.


    • 1 April 2014
      • Vol. 17  (4) , 365-8

    [Feasibility of radical laparoscopy-assisted gastrectomy for patients with chronic obstructive pulmonary disease].

    by Ao Xu, Yongliang Zhao, Feng Qian, Yan Shi, Yingxue Hao, Bo Tang, Huaxing Luo, Peiwu Yu

    To assess the effect of radical laparoscopy-assisted gastrectomy(LG) for patients with chronic obstructive pulmonary disease (COPD). Clinical data of 340 gastric cancer patients with COPD undergoing radical gastrectomy with lymphadenectomy at Southwest Hospital, Third Military Medical University between January 2010 and October 2013 were analyzed retrospectively. The clinical outcomes for the 262 patients with COPD who underwent LG(LG group) were compared with those of 78 patients with COPD who underwent open gastrectomy(OG group). During LG, pneumoperitoneum was maintained at an insuffiation pressure of 8 mmHg to 10 mmHg. The primary endpoint was postoperative pulmonary complication(PPC). To predict factors related to PPC, univariate and multivariate logistic analyses were carried out. Intraoperative blood loss was significantly less in the LG group [(131.2±14.7) ml] than in the OG group [(246.7±49.0) ml; t=-13.445, P=0.000], but operation time was significantly longer [(220.4±19.1) min vs. (194.2±31.5) min; t=6.877, P=0.000]. The findings showed PPC to be significantly less frequent in the LG group(5.3%,14/262) than in the OG group (15.4%, 12/78)(χ(2)=8.581, P=0.003). The severity of COPD was independent risk factor for PPC(P=0.031, HR=1.456, 95%CI:1.306-1.789). No independent predictor of PPCs was found in type of operative approach (open vs laparoscopic; P=0.126). The LG procedure with insuffiation pressure of pneumoperitoneum is tolerated for gastric cancer patients with mild or moderate COPD.


  • Robotic gastrectomy versus laparoscopic gastrectomy for gastric cancer: comparison of surgical performance and short-term outcomes

    by Zhou Junfeng, Shi Yan, Tang Bo, Hao Yingxue, Zeng Dongzhu, Zhao Yongliang, Qian Feng, Yu Peiwu

    This study was designed to compare robot-assisted gastrectomy with laparoscopy-assisted gastrectomy in surgical performance and short-term clinical outcomes for gastric cancer and evaluate the safety and feasibility of robotic surgery. A retrospective database of patients who underwent robotic or laparoscopic gastrectomy for gastric cancer between March 2010 and May 2013 was examined. After screening, 514 patients who underwent gastrectomy for gastric cancer were enrolled in this study: 120 robotic and 394 laparoscopic surgery. Patient demographics, surgical performance, and short-term clinical outcomes were examined. All operations were performed successfully. The clinicopathologic characteristics were similar between the two groups. Compared with the laparoscopic group, the robotic group had less intraoperative blood loss (118.3 ± 55.8 vs. 137.6 ± 61.6 ml, P < 0.001), more lymph nodes dissection (34.6 ± 10.9 vs. 32.7 ± 11.2, P = 0.013), and longer operation time (234.8 ± 42.4 vs. 221.3 ± 44.8 min, P = 0.003). The survival rates were 90.2 % at 1 year, 78.1 % at 2 years, and 67.8 % at 3 years in the RAG group compared with 87.3 % at 1 year, 77.1 % at 2 years, and 69.9 % at 3 years in the LAG group. The difference in overall survival rate between the two groups was not statistically significant (P = 0.812). In view of lymph node involvement, the 3-year survival rates for patients with negative nodal metastasis were 84.4 % in the RAG group versus 82.6 % in the LAG group (P = 0.972) and 57.5 % in the RAG group versus 60.3 % in the LADG group (P = 0.653) for those with positive nodal metastasis. Comparing well with laparoscopic gastrectomy, robot-assisted gastrectomy is a feasible and safe surgical procedure with clear operation field, precise dissection, minimal trauma, and fast recovery. Longer follow-up time and randomized, clinical trials are needed to evaluate the clinical benefits and long-term oncological outcomes of this new technology.